Annual advances of traditional medicine on tumor immunity regulation in 2020

Journal Title: Traditional Medicine Research - Year 2021, Vol 6, Issue 3

Abstract

Tumor burden remains a global health problem that threatens human life worldwide. Over the past few years, the evolution of immune checkpoint inhibitors has represented one of the most successful approaches in the field of tumor therapy. Drugs regulating tumor immune microenvironment or enhancing body immunity have indicated a novel perspective to treat tumors. Therefore, an increased number of scientists have been shifting their research focus to explore the immunity regulation effects of anti-tumor traditional medicine or natural products. In this review, we summarize the research progress of traditional medicines on tumor immunity regulation in 2020. Our findings suggest that more herbal medicine-derived phytochemicals and formulas were derived from traditional Chinese medicine, and more papers were published in comprehensive journals. Traditional medicine can comprehensively regulate the tumor immune microenvironment, including natural killer cells, dendritic cells, CD4+/CD8+T lymphocytes, regulatory T cells, myeloid-derived suppressor cells, tumor-associated macrophages, immunosuppressive factors, and immune checkpoints. In 2020, a greater number of research papers focused on active ingredients and formulas that regulate tumor-associated macrophages and immune checkpoints. Active ingredients such as flavonoids became a global hotspot in 2020. Certain natural products were also found to exert synergistic anti-tumor activity with immune checkpoint inhibitors, such as curcumin. However, a distinct lack of high-quality experimental and clinical studies remains a prevalent and challenging issue that hinders the further development of traditional medicine.

Authors and Affiliations

Xue Yang, Xin-Yuan Luan

Keywords

Related Articles

Long-term effect of Chinese herbal medicine Tianqi Capsule on the incidence of diabetes: an 8-year cohort study protocol

Background:The rapid growth of type 2 diabetes mellitus (T2DM) remains a big challenge for clinicians worldwide. Traditional Chinese medicine may bring a new approach for solving this problem. The Tianqi Capsule Diabetes...

The role of Si-Jun-Zi decoction in the management of gastric precancerous lesions and its mechanism

Gastric cancer remains one of the most common and aggressive malignant tumors worldwide. The occurence of gastric cancer experiences a cascade of multistep gastric carcinogenesis, starting from inflammation, metaplasia,...

TMR:A new star for the research of traditional medicine

After several years of preparation, we are excited that Traditional Medicine Research (TMR), an electronic English international academic journal in the field of traditional medicine, is now being launched. As one of the...

Study on an innovative natural drug for Alzheimer's disease reported as a sham

The number of patients with dementia is estimated to be as high as 24 million and is predicted to double every 20 years, i.e., by 2040, leading to a tremendous financial disease burden [1]. Therefore, we urgently need to...

A prospective, randomized controlled trial of sanguisorba oil in the treatment of tamoxifen-related vaginitis in breast cancer patients

This study provides further insights into the clinical efficacy of sanguisorba oil in the treatment of tamoxifen-related (TAM) vaginitis in breast cancer patients. Sanguisorba oil for external use was effective in the tr...

Download PDF file
  • EP ID EP693637
  • DOI 10.12032/TMR20210313223
  • Views 92
  • Downloads 0

How To Cite

Xue Yang, Xin-Yuan Luan (2021). Annual advances of traditional medicine on tumor immunity regulation in 2020. Traditional Medicine Research, 6(3), -. https://europub.co.uk/articles/-A-693637